Attention network test reveals alerting network dysfunction in multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 1, 2010, Pages 93-99

  Urbanek, Carsten ^a   Weinges Evers, Nicholetta ^a   Bellmann Strobl, Judith ^a   Bock, Markus ^a   Dörr, Jan ^a   Hahn, Eric ^a   Neuhaus, Andres H ^a   Opgen Rhein, Carolin ^a   Thi Minh Tam Ta, ^a   Herges, Katja ^a   Pfueller, Caspar F ^a   Radbruch, Helena ^a   Wernecke, Klaus D ^a   Ohlraun, Stephanie ^a   Zipp, Frauke ^a   Dettling, Michael ^a   Paul, Friedemann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cognitive impairment; Multiple sclerosis; Outcome measurement

Indexed keywords

ADULT; ALERTNESS; ARTICLE; ASSOCIATION; ATTENTION; ATTENTION NETWORK TEST; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT;

ADULT; ATTENTION; COGNITION DISORDERS; CONFLICT (PSYCHOLOGY); CROSS-SECTIONAL STUDIES; CUES; DATA INTERPRETATION, STATISTICAL; DEPRESSION; DISABILITY EVALUATION; DISEASE PROGRESSION; FATIGUE; FEMALE; FIXATION, OCULAR; HUMANS; MALE; MULTIPLE SCLEROSIS; NERVE NET; PHOTIC STIMULATION; REACTION TIME;

EID: 73949088796     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509350308     Document Type: Article

References (46)

1. Hoffmann S., Tittgemeyer M., von Cramon DY Cognitive impairment in multiple sclerosis. Curr Opin Neurol 2007 ; 20: 275 280.
2. Amato MP, Ponziani G., Siracusa G., Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001 ; 58: 1602 1606.
3. Rao SM, Leo GJ, Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. frequency, patterns, and prediction. Neurology 1991 ; 41: 685 691.
4. Prakash RS, Snook EM, Lewis JM, Motl RW, Kramer AF Cognitive impairments in relapsing remitting multiple sclerosis: a meta-analysis. Mult Scler 2008 ; 14: 1250 1261.
5. Paul RH, Beatty WW, Schneider R., Blanco C., Hames K. Impairments of attention in individuals with multiple sclerosis. Mult Scler 1998 ; 4: 433 439.
6. Bobholz JA, Rao SM Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003 ; 16: 283 288.
7. Posner MI, Petersen SE The attention system of the human brain. Annu Rev Neurosci 1990 ; 13: 25 42.
8. Fan J., McCandliss BD, Sommer T., Raz A., Posner MI Testing the efficiency and independence of attentional networks. J Cogn Neurosci 2002 ; 14: 340 347.
9. Fan J., Gu X., Guise KG, et al. Testing the behavioral interaction and integration of attentional networks. Brain Cogn 2009 ; 70: 209 220.
10. Posner MI Measuring alertness. Ann N Y Acad Sci 2008 ; 1129: 193 199.
11. Neuhaus AH, Opgen-Rhein C., Urbanek C., et al. Spatiotemporal mapping of sex differences during attentional processing. Hum Brain Mapp 2009 ; 30: 2997 3008.
12. Fan J., McCandliss BD, Fossella J., Flombaum JI, Posner MI The activation of attentional networks. Neuroimage 2005 ; 26: 471 479.
13. Urbanek C., Neuhaus AHM, Opgen-Rhein C., et al. Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia. Psychiatry Res 2009 ; 168: 102 109.
14. Opgen-Rhein C., Neuhaus AH, Urbanek C., Hahn E., Sander T., Dettling M. Executive attention in schizophrenic males and the impact of comt val108/158met genotype on performance on the attention network test. Schizophr Bull 2008 ; 34: 1231 1239.
15. Neuhaus AH, Koehler S., Opgen-Rhein C., Urbanek C., Hahn E., Dettling M. Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study. J Psychiatr Res 2007 ; 41: 635 644.
16. Tales A., Muir JL, Bayer A., Jones R., Snowden RJ Phasic visual alertness in alzheimers disease and ageing. Neuroreport 2002 ; 13: 2557 2560.
17. Gruber S., Rathgeber K., Braãnig P., Gauggel S. Stability and course of neuropsychological deficits in manic and depressed bipolar patients compared to patients with major depression. J Affect Disord 2007 ; 104: 61 71.
18. Fernandez-Duque D., Black SE Attentional networks in normal aging and alzheimers disease. Neuropsychology 2006 ; 20: 133 143.
19. Halterman CI, Langan J., Drew A., et al. Tracking the recovery of visuospatial attention deficits in mild traumatic brain injury. Brain 2006 ; 129: 747 753.
20. Polman CH, Reingold SC, Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 2005 ; 58: 840 846.
21. Sheehan DV, Lecrubier Y., Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998 ; 59 (Suppl 20). 22 33 ; quiz 34 57.
22. Beck AT, Ward CH, Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961 ; 4: 561 571.
23. Fisk JD, Pontefract A., Ritvo PG, Archibald CJ, Murray TJ The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994 ; 21: 9 14.
24. Krupp LB, LaRocca NG, Muir-Nash J., Steinberg AD The fatigue severity scale. application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989 ; 46: 1121 1123.
25. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983 ; 33: 1444 1452.
26. Scherer P., Baum K., Bauer H., Göhler H., Miltenburger C. Normalization of the brief repeatable battery of neuropsychological tests (BRB-N) for German-speaking regions. application in relapsing remitting and secondary progressive multiple sclerosis patients. Nervenarzt 2004 ; 75: 984 990.
27. Fan J., Byrne J., Worden MS, et al. The relation of brain oscillations to attentional networks. J Neurosci 2007 ; 27: 6197 6206.
28. Marrocco RT, Witte EA, Davidson MC Arousal systems. Curr Opin Neurobiol 1994 ; 4: 166 170.
29. Dye MWG, Baril DE, Bavelier D. Which aspects of visual attention are changed by deafness? The case of the Attentional Network Test. Neuropsychologia 2007 ; 45: 1801 1811.
30. Wang K., Fan J., Dong Y., Wang CQ, Lee TMC, Posner MI Selective impairment of attentional networks of orienting and executive control in schizophrenia. Schizophr Res 2005 ; 78: 235 241.
31. Gooding DC, Braun JG, Studer JA Attentional network task performance in patients with schizophrenia-spectrum disorders: evidence of a specific deficit. Schizophr Res 2006 ; 88: 169 178.
32. Rao SM Neuropsychology of multiple sclerosis. Curr Opin Neurol 1995 ; 8: 216 220.
33. Houtchens MK, Benedict RHB, Killiany R., et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007 ; 69: 1213 1223.
34. Davies GR, Altmann DR, Rashid W., et al. Emergence of thalamic magnetization transfer ratio abnormality in early relapsing remitting multiple sclerosis. Mult Scler 2005 ; 11: 276 281.
35. Ceccarelli A., Filippi M., Neema M., et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult Scler 2009 ; 15: 678 686.
36. Geurts JJG, Reuling IEW, Vrenken H., et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 2006 ; 55: 478 483.
37. Inglese M., Park SJ, Johnson G., et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 t. Arch Neurol 2007 ; 64: 196 202.
38. Ge Y., Jensen JH, Lu H., et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007 ; 28: 1639 1644.
39. Cifelli A., Arridge M., Jezzard P., Esiri MM, Palace J., Matthews PM Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002 ; 52: 650 653.
40. Vercellino M., Masera S., Lorenzatti M., et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009 ; 68: 489 502.
41. Schiff ND Central thalamic contributions to arousal regulation and neurological disorders of consciousness. Ann N Y Acad Sci 2008 ; 1129: 105 118.
42. Wiegmann K., Muthyala S., Kim DH, Arnason BG, Chelmicka-Schorr E. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol 1995 ; 56: 201 206.
43. Rajda C., Bencsik K., Vécsei LL, Bergquist J. Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients. J Neuroimmunol 2002 ; 124: 93 100.
44. Rajda C., Bencsik K., Fãvesi J., Seres E., Vécsei L., Bergquist J. The norepinephrine level is decreased in the lymphocytes of long-term interferon-beta-treated multiple sclerosis patients. Mult Scler 2006 ; 12: 265 270.
45. Flachenecker P., Reiners K., Krauser M., Wolf A., Toyka KV Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 2001 ; 7: 327 334.
46. Pantano P., Mainero C., Caramia F. Functional brain reorganization in multiple sclerosis: evidence from FMRI studies. J Neuroimaging 2006 ; 16: 104 114.